000 01331 a2200385 4500
005 20250517142318.0
264 0 _c20170530
008 201705s 0 0 eng d
022 _a1532-2149
024 7 _a10.1002/ejp.995
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aFavre-Guilmard, C
245 0 0 _aBilateral analgesic effects of abobotulinumtoxinA (Dysport
_h[electronic resource]
260 _bEuropean journal of pain (London, England)
_c05 2017
300 _a927-937 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAnalgesics
_xpharmacology
650 0 4 _aAnimals
650 0 4 _aBotulinum Toxins, Type A
_xpharmacology
650 0 4 _aChronic Pain
_xdrug therapy
650 0 4 _aDiabetic Neuropathies
_xdrug therapy
650 0 4 _aDisease Models, Animal
650 0 4 _aHyperalgesia
_xdrug therapy
650 0 4 _aInflammation
_xdrug therapy
650 0 4 _aMale
650 0 4 _aPain Threshold
_xdrug effects
650 0 4 _aPolyneuropathies
_xdrug therapy
650 0 4 _aRats
650 0 4 _aRats, Sprague-Dawley
650 0 4 _aSpinal Cord
_xdrug effects
700 1 _aChabrier, P-E
700 1 _aKalinichev, M
773 0 _tEuropean journal of pain (London, England)
_gvol. 21
_gno. 5
_gp. 927-937
856 4 0 _uhttps://doi.org/10.1002/ejp.995
_zAvailable from publisher's website
999 _c26938768
_d26938768